Treatment of irritable bowel syndrome in women
Irritable bowel syndrome (IBS) is a complex clinical process with multiple pathophysiologic mechanisms. There has recently been a shift in the treatment of patients with severe IBS symptoms to disease-modifying therapies as opposed to symptomatic treatment. Because pathophysiologic differences exist...
Saved in:
Published in | Gastroenterology clinics of North America Vol. 40; no. 2; p. 265 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2011
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | Irritable bowel syndrome (IBS) is a complex clinical process with multiple pathophysiologic mechanisms. There has recently been a shift in the treatment of patients with severe IBS symptoms to disease-modifying therapies as opposed to symptomatic treatment. Because pathophysiologic differences exist between men and women, so does the efficacy of treatment options. These differences could further explain gender-related differences in disease prevalence and treatment response. A brief discussion of the definition, epidemiology, and diagnostic criteria of IBS is followed by a comprehensive review of the current treatment choices and potential future therapeutic options of IBS in women. |
---|---|
ISSN: | 1558-1942 |
DOI: | 10.1016/j.gtc.2011.03.012 |